Such information could be of clinical value in the diagnosis, longitudinal monitoring of disease progression and efficacy evaluation of treatments in retinal disorders with altered rhodopsin expression in photoreceptors or actual photoreceptor loss. The gene discussed is RHO; the disease is retinal disorder.